Faculty of Medicine, Department of Ophthalmology, Erciyes University, Kayseri, Turkey.
Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Marmara University, İstanbul, Turkey.
Photodiagnosis Photodyn Ther. 2022 Jun;38:102806. doi: 10.1016/j.pdpdt.2022.102806. Epub 2022 Mar 11.
Background To investigate whether single retinal layer, choroidal and peripapillary retinal fiber layer thicknesses were affected in patients under hydroxychloroquine treatment without retinal toxicity Methods Forty-nine patients under hydroxychloroquine treatment (HCQ group) and 39 healthy volunteers, a total of 88 individuals, were included in the study. Patients with HCQ treatment were further divided into two groups as less than 5 years of HCQ use (group 1, 29 patients) and 5 years or more of HCQ use (group 2, 20 patients). All participants underwent full ophthalmologic examination and optical coherence tomography (OCT) imaging as OCT is a recommended tool for screening toxicity by the American Association of Ophthalmology. The automatic segmentation of retinal layers included retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), retina pigment epithelium (RPE), inner retinal layers (IRL), outer retinal layers (ORL) and total retina thickness (TRT). Choroidal thickness (ChT), choroidal vascularity index and peripapillary RNFL were also measured. Results Both inferior and nasal parafoveal RNFL, temporal parafoveal GCL, and IPL layer thicknesses were decreased, while temporal parafoveal RPE layer thicknesses were increased in hydroxychloroquine users. Subfoveal ChTs were significantly reduced in both groups 1 and 2 compared to the control group(p = 0.042 and p = 0.009, respectively) and temporal ChT thicknesses were statistically decreased in group 2 compared to the control group(p = 0.018), but not for nasal ChT. Conclusions Hydroxychloroquine use may cause parafoveal retinal layer thickness alterations and also subfoveal and parafoveal ChT alterations even without evident retinal toxicity in OCT.
研究羟氯喹治疗下无视网膜毒性的患者是否受单一视网膜层、脉络膜和视盘周围视网膜纤维层厚度的影响。
共纳入 88 名研究对象,包括 49 名接受羟氯喹治疗的患者(HCQ 组)和 39 名健康志愿者。将接受 HCQ 治疗的患者进一步分为使用 HCQ 治疗<5 年(组 1,29 例)和 5 年或以上(组 2,20 例)。所有参与者均接受全面眼科检查和光学相干断层扫描(OCT)成像,因为 OCT 是美国眼科学会推荐的筛查毒性的工具。视网膜层的自动分割包括视网膜神经纤维层(RNFL)、神经节细胞层(GCL)、内丛状层(IPL)、内核层(INL)、外丛状层(OPL)、外核层(ONL)、视网膜色素上皮(RPE)、内视网膜层(IRL)、外视网膜层(ORL)和总视网膜厚度(TRT)。还测量了脉络膜厚度(ChT)、脉络膜血管指数和视盘周围 RNFL。
羟氯喹使用者的下方和鼻侧旁中心凹 RNFL、颞侧旁中心凹 GCL 和 IPL 层厚度降低,而颞侧旁中心凹 RPE 层厚度增加。与对照组相比,组 1 和组 2 的黄斑下 ChT 均显著降低(p=0.042 和 p=0.009),组 2 的颞侧 ChT 厚度与对照组相比也有统计学意义的降低(p=0.018),但鼻侧 ChT 则没有。
即使在 OCT 中没有明显的视网膜毒性,羟氯喹的使用也可能导致旁中心凹视网膜层厚度改变以及黄斑下和旁中心凹脉络膜厚度改变。